Prospective Role of Citicoline and Hyaluronated Nanotechnology as Drug Delivery A pproaches for Alzheimer’s Disease: Review of the Literature

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the Extracellular Matrix in Alzheimer’s Disease

  2021cited by this paper
• Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.

  2021cited by this paper
• A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease

  2021cited by this paper
• Synaptic Hyaluronan Synthesis and CD44-Mediated Signaling Coordinate Neural Circuit Development

  2021cited by this paper
• The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease

  2021cited by this paper
• NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease

  2021cited by this paper
• Nanocarriers as an Emerging Platform for Cancer Therapy

  2020cited by this paper
• Modeling the effects of hyaluronic acid degradation on the regulation of human astrocyte phenotype using multicomponent interpenetrating polymer networks (mIPNs)

  2020cited by this paper
• ZOLMITRIPTAN BRAIN TARGETING VIA INTRANASAL ROUTE USING SOLID LIPID NANOPARTICLES FOR MIGRAINE THERAPY: FORMULATION, CHARACTERIZATION, IN-VITRO AND IN-VIVO ASSESSMENT

  2020cited by this paper
• Effects of Citicoline as an Adjunct Treatment for Alzheimer’s Disease: A Systematic Review

  2020cited by this paper
• Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics.

  2020cited by this paper
• Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

  2020cited by this paper
• Erratum: Author Correction: History and progress of hypotheses and clinical trials for Alzheimer's disease.

  2019cited by this paper
• Quantitative CT parameters correlate with lung function in chronic obstructive pulmonary disease: A systematic review and meta-analysis

  2019cited by this paper
• Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.

  2019cited by this paper
• Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.

  2019cited by this paper
• Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

  2018cited by this paper
• Nanotechnology‐based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges

  2017cited by this paper
• The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer’s Disease Study

  2016cited by this paper
• Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management

  2016cited by this paper
• Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF(165).

  2016cited by this paper
• The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system

  2016cited by this paper
• Hyaluronic acid for anticancer drug and nucleic acid delivery.

  2016cited by this paper
• Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery

  2016cited by this paper
• Hyaluronan Synthase: The Mechanism of Initiation at the Reducing End and a Pendulum Model for Polysaccharide Translocation to the Cell Exterior

  2015cited by this paper
• Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer

  2015cited by this paper
• Bilosomes Based Drug Delivery System

  2015cited by this paper
• Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis.

  2015cited by this paper
• Neuroprotective Properties of Citicoline: Facts, Doubts and Unresolved Issues

  2014cited by this paper
• An overview of clinical and commercial impact of drug delivery systems.

  2014cited by this paper
• Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.

  2014cited by this paper
• Central nervous system stimulants and drugs that suppress appetite

  2014cited by this paper
• Formulation, in vitro and in vivo Characterisation of Diclofenac Potassium Sustained Release Tablets Based on Solidified Reverse Micellar Solution (SRMS)

  2013cited by this paper
• Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid.

  2013cited by this paper
• SIRT1 and SIRT2: emerging targets in neurodegeneration

  2013cited by this paper
• Tau protein kinases: involvement in Alzheimer's disease.

  2013cited by this paper
• Nanosuspension improves tretinoin photostability and delivery to the skin.

  2013cited by this paper
• Potential of a Cryopreserved Cultured Dermal Substitute Composed of Hyaluronic Acid and Collagen to Release Angiogenic Cytokine

  2013cited by this paper
• Memory loss in Alzheimer's disease

  2013cited by this paper
• Citicoline (CDP‐choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke

  2013cited by this paper
• Primary Hippocampal Neurons, Which Lack Four Crucial Extracellular Matrix Molecules, Display Abnormalities of Synaptic Structure and Function and Severe Deficits in Perineuronal Net Formation

  2013cited by this paper
• New diagnostic concepts in Alzheimer’s disease

  2013cited by this paper
• Ethosomes: A Novel Drug Carrier

  2013cited by this paper
• NOVEL APPROACHES IN LIPID BASED DRUG DELIVERY SYSTEMS

  2013cited by this paper
• Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

  2013cited by this paper
• Systematic Development of Self-Emulsifying Drug Delivery Systems of Atorvastatin with Improved Bioavailability Potential

  2012cited by this paper
• Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

  2012cited by this paper
• Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study

  2012cited by this paper
• The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.

  2012cited by this paper
• Critical issues related to transfersomes - novel vesicular system.

  2012cited by this paper
• CURRENT TRENDS IN LIPID BASED DELIVERY SYSTEMS AND ITS APPLICATIONS IN DRUG DELIVERY

  2012cited by this paper
• Amyloid precursor protein processing and Alzheimer's disease.

  2011cited by this paper
• Formulation of solid lipid nanoparticles and their applications.

  2011cited by this paper
• Nonionic surfactant vesicular systems for effective drug delivery—an overview

  2011cited by this paper
• Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia.

  2011cited by this paper
• A REVIEW: SELF EMULSIFYING DRUG DELIVERY SYSTEM

  2011cited by this paper
• Alzheimer's disease: clinical trials and drug development

  2010cited by this paper
• Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: Amyloidogenesis and therapeutic strategies—A review

  2010cited by this paper
• Transferosomes: A Novel Approach for Transdermal Drug Delivery

  2009cited by this paper
• Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery

  2009cited by this paper
• The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

  2009cited by this paper
• Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases

  2009cited by this paper
• Variability in the Prescription of Cholinesterase Inhibitors and Memantine

  2009cited by this paper
• Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®)

  2008cited by this paper
• Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies

  2008cited by this paper
• Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.

  2008cited by this paper
• Sulfated Polysaccharides Promote the Assembly of Amyloid β1–42 Peptide into Stable Fibrils of Reduced Cytotoxicity*

  2008cited by this paper
• Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions.

  2007cited by this paper
• Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications

  2007cited by this paper
• Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity.

  2006cited by this paper
• Hyaluronan fragments: an information-rich system.

  2006cited by this paper
• The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light‐chain protein

  2006cited by this paper
• CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke.

  2005cited by this paper
• Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice.

  2005cited by this paper
• Visual acuity in optic atrophy: a quantitative clinicopathological analysis

  2005cited by this paper
• Vesicles as a tool for transdermal and dermal delivery.

  2005cited by this paper
• Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns

  2005cited by this paper
• Tau pathology in Alzheimer disease and other tauopathies.

  2005cited by this paper
• The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats.

  2004cited by this paper
• Loading mitomycin C inside long circulating hyaluronan targeted nano‐liposomes increases its antitumor activity in three mice tumor models

  2004cited by this paper
• Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A.

  2004cited by this paper
• Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin.

  2004cited by this paper
• Alzheimer's disease pathogenesis and therapeutic interventions.

  2004cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.

  2004cited by this paper
• Long-Term Citicoline (Cytidine Diphosphate Choline) Use in Patients with Vascular Dementia: Neuroimaging and Neuropsychological Outcomes

  2003cited by this paper
• Neuropathologic changes in Alzheimer's disease.

  2003cited by this paper
• Mammalian Hyaluronan Synthases

  2002cited by this paper
• Citicoline Treatment Increases Retinal Dopamine Content in Rabbits

  2002cited by this paper
• Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.

  2002cited by this paper
• Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice

  2002cited by this paper
• [New strategies in the management of retinoblastoma].

  2002cited by this paper
• Oral Citicoline in Acute Ischemic Stroke: An Individual Patient Data Pooling Analysis of Clinical Trials

  2002cited by this paper
• Pharmacodynamics of citicoline relevant to the treatment of glaucoma

  2002cited by this paper
• Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).

  2001cited by this paper
• Solid lipid nanoparticles: production, characterization and applications.

  2001cited by this paper
• New Ultradeformable Drug Carriers for Potential Transdermal Application of Interleukin-2 and Interferon-a Theoretic and Practical Aspects

  2000cited by this paper
• Review: history of the amyloid fibril.

  2000cited by this paper
• Enhancement of transdermal drug delivery: chemical and physical approaches.

  2000cited by this paper
• Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties*

  1999cited by this paper

• The impact of citicoline on brain mitochondrial dysfunction induced in rats after head irradiation

  2025cites this paper